The analysis showed that CLL patients with low UBA7 expression had significantly shorter survival times compared to those with high UBA7 expression (Fig. 7), with the difference being statistically significant (log-rank p-value = 0.0027). This evidence concerns the gene UBA7 and B-cell chronic lymphocytic leukemia.